Paper · 39005199
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.
Kim EJ. Gut Liver, 2024. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma. Papers, record 39005199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39005199
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Palliative Care | Major topic |
| Adenocarcinoma | Major topic |
| Ampulla of Vater | Major topic |
| Common Bile Duct Neoplasms | Major topic |
| Humans | |
| Antineoplastic Combined Chemotherapy Protocols |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 38,130,162 | Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. | https://conductscience.org/library/papers/38130162 |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,433,650 | Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34433650 | PubMed |
| 2 | 19,252,434 | Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. | Am J Surg Pathol | 2009 | https://conductscience.org/library/papers/19252434 | PubMed |
| 3 | 38,130,162 | Outcomes of Palliative Chemotherapy for Ampulla of Vater Adenocarcinoma: A Multicenter Cohort Study. | Gut Liver | 2024 | https://conductscience.org/library/papers/38130162 | PubMed |
| 4 | 34,586,537 | Treatment Approach to Adenocarcinoma of the Ampulla of Vater. | Curr Treat Options Oncol | 2021 | https://conductscience.org/library/papers/34586537 | PubMed |
| 5 | 19,164,203 | Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19164203 | PubMed |
| 6 | 23,994,910 | Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater. | Tohoku J Exp Med | 2013 | https://conductscience.org/library/papers/23994910 | PubMed |
| 7 | 27,611,608 | Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations. | Ann Surg | 2018 | https://conductscience.org/library/papers/27611608 | PubMed |
| 8 | 18,369,675 | Survival after resection of ampullary carcinoma: a national population-based study. | Ann Surg Oncol | 2008 | https://conductscience.org/library/papers/18369675 | PubMed |
| 9 | 20,375,404 | Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20375404 | PubMed |
| 10 | 37,504,367 | Ampullary Cancer: Histological Subtypes, Markers, and Clinical Behaviour-State of the Art and Perspectives. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37504367 | PubMed |
Cited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39005199
GET https://conductscience.org/api/papers/v1/39005199/authors